Buspirone Shortage in Healthcaristan SSR episode artwork

EPISODE · May 3, 2019 · 20 MIN

Buspirone Shortage in Healthcaristan SSR

from Astral Codex Ten Podcast

(Epistemic status: Unsure on details. Some post-publication edits 5/1 to make this less strident.) I. There is a national shortage of buspirone. Buspirone is a 5HT-1 agonist used to control anxiety. Unlike most psychiatric drugs, it's in a class of its own – there are no other sole 5HT-1 agonists on the market. It's not a very strong medication, but it's safe, it's non-addictive, it's off-patent, and it works well for a subset of patients. Some of them have been on it for years.  Now there's a national shortage. My patients can't get it, or have to go hunting from pharmacy to pharmacy until they find one that has it. I've told people find a source to stockpile a supply so they don't run out. It feels like we're living in the Soviet Union. How did this happen? The New York Times writes: The main reason for the buspirone shortage appears to be interrupted production at a Mylan Pharmaceuticals plant in Morgantown, W.Va., which produced about a third of the country's supply of the drug. The Food and Drug Administration had said the facility was dirty and that the company failed to follow quality control procedures.

Episode metadata supplied by the publisher feed · Published May 3, 2019

Embed this episode

NOW PLAYING

Buspirone Shortage in Healthcaristan SSR

0:00 20:25

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Astral Codex Ten Podcast?

This episode is 20 minutes long.

When was this Astral Codex Ten Podcast episode published?

This episode was published on May 3, 2019.

Can I download this Astral Codex Ten Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!